Alexion Pharmaceuticals - WACEP Virtual Exhibit Hall



 CONTACT INFO

Address & Phone:

121 Seaport Blvd

Boston, MA 02210

414-305-7708


Contact: Heather Nelson

heather.nelson@alexion.com
COMPANY INFO

Alexion is a global biopharmaceutical company with the mission of helping the lives of people affected by rare diseases by continuously innovating and creating meaningful value in all that we do. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

View/download our handouts:

Soliris® (eculizumab) is the FIRST AND ONLY FDA-approved complement inhibitor indicated for the treatment of adults with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD)

Soliris: By helping control anti-AChR antibody-positive gMG symptoms, your adult patients’ activities may become everyday victories.

Soliris® (eculizumab) Initiation Guide




Return to the Virtual Exhibit Hall 

Wisconsin ACEP makes every attempt to provide accurate and timely content available for users. Neither WACEP nor third-party content providers are responsible or liable for any such content, including advertising, products or other materials available through third party sites.